Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPEROXIA in vascular surgery
NCT02562781Phase 3Completed
- Sponsor
- Örebro University
- Start
- Nov 2014
- Primary completion
- Dec 2020
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of oxygen in vascular disease (2 arms), sponsored by Örebro University. Primary endpoint: Composite morbidity at 1 month. Started Nov 2014; status: completed.
02
Drugs
oxygen
03
Conditions
vascular disease
Beyond the preview
Go deeper on NCT02562781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562781.